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Summary: A new method for the spectrophotometric determination of Evans Blue in plasma is presented. The
method is based on the precipitation of the non-albumin fraction of the plasma proteins with polyethylene glycol,
in order to eliminate the variable background absorption of plasma at the wavelength of maximum absorbance of
Evans Blue. The accuracy and precision of the method is excellent: at an Evans Blue concentration in plasma of
5 mg · 1 the coefficient of variation of the method is < 1 %. Five different procedures currently in use for the calcula-
tion of the plasma volume from the amount of indicator injected and the concentration at zero time (c0) were com-
pared. Extrapolation to zero time of the early part (10 to 60 min) of the log concentration vs time curve turned out
to be the best method for the calculation of c0, and hence yields the best estimate of the plasma volume.
Eine verbesserte Methode fur die Bestimmung des Plasmavolumens mit Evans Blue
Zusammenfassung: Eine neue Methode für die spektrophotometrische Bestimmung von Evans Blue wird beschrieben.
Sie beruht auf der Fällung der Nicht-Albumin-Fraktion der Plasmaproteine mit Polyethylenglycol, um die variierende
Untergrundabsorption von Plasma bei der Wellenlänge des Absorptionsmaximums von Evans Blue zu eliminieren.
Richtigkeit und Genauigkeit der Methode sind hervorragend: bei einer Evans Blue-Konzentration von 5 mg/1 Plasma
ist der Variationskoeffizient der Methode < 1%. Fünf verschiedene Verfahren, die gegenwärtig zur Ermittlung des
Plasmavolumens aus der Menge an injiziertem Indikator und der Konzentration zum Zeitpunkt t = 0 (c0) Verwendung
finden, wurden verglichen. Extrapolation des frühen Teils (10-60 min) der log Konzentration gegen Zeit-Kurve auf
die Zeit t = 0 erwies sich als die beste Methode für die Ermittlung von c0 und ergibt deshalb den besten Wert für das
Plasmavolumen.
Introduction
The plasma volume can be measured by indicator dilu-
tion, using albumin labelled with Evans Blue (T-1824),
or with radio-iodine. All methods described up to now
for the determination of Evans Blue in plasma (1) are
based on one of the following principles:
1. spectrophotometry against a plasma blank;
2. two-wavelength spectrophotometry;
3. spectrophotometry after extraction of the dye.
Because of the many difficulties encountered in the use
of these methods, Evans Blue has almost gone out of use.
In this investigation we have tried to improve the deter-
mination. Poison & Ruiz-Bravo (2) reported the use of
polyethylene glycol in the fractionation of plasma pro-
teins. Unlike the majority of the protein fractionation
agents, polyethylene glycol separates components from
a mixture by a volume exclusion mechanism. The easy
and accurate method for the determination of Evans
Blue in plasma described in this paper is based on the
precipitation with polyethylene glycol of all proteins
except albumin. It can be used in plasmas of widely
divergent opacity and in plasmas with some degree of
haemolysis.
Furthermore, using dogs, we have performed a series of
experiments to compare the different methods in use
for the calculation of the plasma volume with the method
for the calculation of an indicator distribution volume
according to Meier & Zierler (3). This latter method needs
a rather large number of samples and a laborious pro-
cedure to calculate the plasma volume, but it gives the
most accurate results and hence is the best reference
method.
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Methods and Experiments
Determination of the plasma Evans Blue concentration after
treatment of the plasma with polyethylene glycol
The optimum polyethylene glycol concentration (average relative
molecular mass 4000) for the precipitation of the non-albumin
fraction of the plasma proteins was determined in a preliminary
experiment. Figure 1 shows that after the addition of one part
polyethylene glycol 240 g · Ã1 to one part of human plasma, the
albumin fraction remains dissolved but the other protein fractions
are precipitated almost completely, whereas at higher polyethyl-
ene glycol concentrations part of the albumin fraction is also pre-
cipitated. The precipitation was complete within 10 min. The
same results were obtained in dog plasma. On the basis of these
findings the following method was adopted.
1. Add 1 part polyethylene glycol 240 g · Ã1 to 1 part plasma.
2. Allow to stand for 10 min.
3. Spin at 7000 g for 10 min.
4. Read the absorbance of the supernatant against a similarly
treated plasma blank at the wavelength of maximum absorb-
ance (man, ë = 620 nm; dog, ë = 627 nm) and convert the
measured absorbances into concentrations with the aid of a
calibration line, made by mixing different volumes of a
5 g · Ã1 Evans Blue solution in 9 g · Ã1 NaCl with plasma.
At the wavelengths used the absorbance of Evans Blue obeys
Lambert-Beer's law at least from 1.5 to 25 mg · Ã1 (r = 0.9999)
with an absorptivity of 0.039 1 · mg"1 · cm"1 in human and dog
plasma.
Other methods for the determination of the plasma Evans Blue
concentration
In a number of experiments the plasma Evans Blue concentration
was also determined with a signle-wavelength method (4), a two-
wavelength method (5) and an acetone extraction method (6).
Experiments in vitro
To determine whether treatment with polyethylene glycol suffi-
ciently reduces the background absorption caused by opacity and
slight haemolysis, the absorbance at ë = 620 nm (A62o) was
measured in a series of 68 human plasma samples (normal, lipae-
mic, haemolytic with a haemoglobin concentration up to
1.2 g · Ã1) and at ë = 627 nm 0462?) in a series of 26 dog plasma
samples, before and after treatment with polyethylene glycol.
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Fig. 1. Effect of polyethylene glycol on the solubility of the
plasma proteins. Equal parts of polyethylene glycol solu-
tions (concentrations given under each column) and
plasma were mixed at room temperature. The amount of
albumin (hatched columns) and non-albumin fraction
(white columns) remaining in solution is given in g · Ã1
plasma.
To test whether the plasma protein concentration influences the
absorbance of Evans Blue after polyethylene glycol treatment,
human and dog plasma was diluted with NaCl 9 g · Ã1 to get pro-
tein concentrations from 20 to 70 g · Ã1. To 1.5 ml of these
solutions 3 ìÀ Evans Blue solution 5 g · Ã1 was added and ^ 020
and Ë 627 measured after treatment with polyethylene glycol.
To study the influence of haemoglobin on the absorbance of
Evans Blue after treatment with polyethylene glycol, a haemo-
lysate was added to dog plasma to obtain haemoglobin concen-
trations from 0 to 0.2 g · Ã1. To 1.5 ml of these solutions 3 ìÀ
Evans Blue solution 5 g · Ã1 was added and ,4 $27 measured after
treatment with polyethylene glycol.
To determine the precision of the method, Evans Blue was added
to plasma to a concentration of 2.5, 5, 7.5 and 10 g · Ã1 and 20
replicate determinations were run on these samples. To determine
the accuracy of the polyethylene glycol method in comparison
with other methods, Evans Blue was added to different plasma
samples to a concentration of 5 mg · Ã1 and the Evans Blue
concentrations determined with the single-wavelength method,
the two-wavelength method, the acetone extraction method and
the polyethylene glycol method.
Experiments in vivo
The plasma volume (VP) was determined in 10 male mongrel
dogs (23-33 kg) with permanent vascular catheters (7). All
animals were in good health with body temperatures between
38.5 and 38.9 °C; they were fed with standard pellets (Hope
Farms, Woerden, The Netherlands) with the addition of ox tripe,
and had free access to water. The dog, lying quietly in a basket,
was given 1 ml per kg body mass of a solution containing
0.4 g · Ã1 Evans Blue in 9 g · Ã1 NaCl as a single injection
through the catheter in the pulmonary artery. The exact
amount of Evans Blue administered was calculated from the
density and the mass of the solution injected, determined by
weighing the syringe to the nearest 0.005 g before and after
the injection. Blood samples were taken before and 1, 2, 5, 7.5,
10,12.5, 15, 20, 30, 40, 50, 60, 70, 80, 90,105,120,135,150,
180 and 240 min after the injection, zero time being chosen half-
way between the start and the end of the injection which took
about 20 s. Blood loss through sampling was compensated for by
intravenous administration of 9 g · Ã1 NaCl solution.
VP was calculated in two different ways. Starting from the rela-
tion volume = flow X transit time, in which the flow is repre-
sented by the clearance of the indicator from the blood stream,
Meier & Zierler (3) showed that
= * (Eql)
in which m1 denotes the amount of indicator injected and ct the
plasma indicator concentration at time t. The concentration ct is
obtained from the plasma indicator concentration vs time curve
which is described over the period 0 to 60 min by two or three
exponential functions. In addition, VP was calculated using the
equation
|
K = J (Eq2)
The indicator concentration at time zero (c0) was obtained in 5
different ways.
A. CQ = 1.015 c10,1.015 being the correction factor for the indica*
tor loss during the first 10 min (8, 9).
0,11).
C. Linear extrapolation of the early disappearance curve, i.e. the
concentration vs time curve from 10 to 60 min (12, 13).
D. Semilogarithmic extrapolation of the early disappearance
curve (14).
E. Semilogarithmic extrapolation of the date disappearance curve,
i.e. the concentration vs time curve from 120 to 240 mih (15).
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Results
Treatment with polyethylene glycol reduced A620 from
0.285 ± 0.153 to 0.024 ± 0.004 in the Evans Blue-free
human plasma samples and A
 62i from 0.158 ± 0.104
to 0.014 ± 0.003 in dog plasma. In human and dog
plasmas with protein concentrations from 20 to 70 g · Ã1
the absorbances of 10 ing - Ã1 Evans Blue were equal,
showing that the absorbance of Evans Blue is not influ-
enced by the plasma protein content. Spectrophoto-
metric assay of haemolytic plasma samples, containing
no added Evans Blue, against a non-haemolytic plasma
blank showed that treatment with polyethylene glycol
strongly diminishes the haemoglobin-caused absorbance
and at cHb < 0.8 g - Ã1, in fact eliminates it. Table 1
shows that the presence of haemolysis does not influ-
ence the recovery of Evans Blue when each sample is read
against its own polyethylene glycol-treated plasma blank.
When each sample is read against the non-haemolytic
polyethylene glycol-treated plasma blank, the influence
of haemolysis can be neglected up to cHb = 0.8 g · Ã1,
but at concentrations above 1.2 g - Ã1 its effect becomes
appreciable. In table 2 the data on the accuracy and
the precision of the method at different concen-
tration levels are given. The recovery of added Evans
Blue is excellent, and at a concentration of 2.5
mg - Ã1 and upwards the coefficient of variation (C.V.)
of the method is < 1 %. Data on the accuracy and pre-
cision of the method in comparison with other methods
are given in table 3. Figure 2 shows a typical early
arterial disappearance curve of Evans Blue in a dog as
determined with the four different measuring methods.
Tab. 1. Recovery of Evans Blue added to plasma (10 mg · Ã1)
with increasing degree of haemolysis after treatment
with polyethylene glycol. Number of experiments 4;
Evans Blue concentration ± s.d.
Evans Blue recovered (mg · Ã1)
read against own read against non-
haemolytic haemolytic
plasma blank plasma blank
d-r1)
0
0.4
0.8
1.2
1,6
2,0
lOiOl ± 0.06
9.96 ± 0,08
9.92 ± 0.07
10.01 ± 0.05
10,07 ± 0.06
10.04 ± 0.08
10.02 ± 0.05
10.06 ± 0.09
10.11 ±0.07
10.23 ± 0.08
10.46 ± 0.09
10.63 ± 0.07
Tab. 2. Recovery and precision of different concentration
levels of Evans Blue in plasma after polyethylene
glycol treatment. Evans Blue concentrations ± s.d.
Evans Blue added
(mg-r*)
2.5
5.0
7.5
10.0
Evans Blue recovered
(mg-r1)
2.503 ± 0.025
5.007 ± 0.024
7.504 ± 0.028
9.997 ± 0.027
Number of
experiments
20
20
20
20
Tab. 3. Accuracy and precision of the polyethylene glycol
method for the determination of Evans Blue in plasma
in comparison with other methods, ç = 10 in each
series.
Method
Single wavelength
Two wavelength
Acetone extraction
Polyethylene giycol
Evans Blue
added
(mg-r1)
5.000
5.000
5.000
5.000
Evans Blue
recovered
(mg-r1)
6.480 ± 1.957
4.894 ± 0.382
5.092 ±0.241
5.006 ± 0.044
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Fig. 2. Evans Blue concentration vs time curve in plasma after
intravenous injection in a dog. The Evans Blue concentra-
tion of the plasma samples was determined with four
different methods. The Evans Blue concentration in
plasma is plotted logarithmically against time. The regres-
sion line is calculated over the period 10 to 60 min.
Methods: a Single wavelength
b Two wavelengths
c Acetone extraction
d Polyethylene glycol precipitation
The variation around the line of best fit is inversely pro-
portional to the accuracy and precision of the methods.
Table 4 presents the values for Vp with their 95% con-
fidence interval in dogs, calculated using Eq. 2 for which
CQ was obtained by semilogarithmic extrapolation to zero
time of the plasma concentration vs time curve over the
period from 10 to 60 min. The plasma Evans Blue con-
centration was determined by the four different methods.
Table 5 presents the values for Vp calculated with Eq. 2
and the plasma Evans Blue concentration determined
with the polyethylene glycol method. For the substitu-
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Tab. 4. Plasma volume (Vp) of conscious dogs as determined
with different methods within the same experiment.
Plasma volume (ml · kg"1 )
Exp.
1
2
3
4
5
6
7
8
9
10
Method
1
94 ±31
48 ± 20
63 ± 3
54 ± 6
90 ±17
57 ± 4
130±51
60± 9
57 ± 4
33 ± 4
2
77 ±6
53 ±4
62 ±2
54 ±4
49 ±7
57 ±3
53 ±6
59 ±5
62 ±2
41 ±3
3
78 ±5
56 ±4
66 ±3
50 ±3
59 ±3
57 ±2
4
78 ± 1
59 ± 1
63 ±1
56 ± 0.5
48± 1
58 ±1
59 ± 0.5
55 ±1
62 ± 0.5
40 ± 0.5
VP was calculated from the amount of Evans Blue in-
jected (m1) and the Evans Blue concentration at zero
time obtained by extrapolation to zero time of the log
indicator vs time curve over the period 10 to 60 min.
1. single wavelength method
2. two wavelength method
3. acetone extraction
4. polyethylene glycol method
Vp per unit of body mass ± 95% confidence interval is
given in ml · kg"1.
Tab. 5. Plasma volume (V?) in conscious dogs calculated with
Eq. 2 from the amount of Evans Blue injected and the
Evans Blue concentration at zero time (c0), the latter
being obtained in different ways.
Exp.
1
2
3
4
5
6
7
8
9
10
Mean
±SD
Vp (Eq. 2)
Vp (Eq. 1)
Method
1
100.626
94.791
101.692
100.771
101.353
102.041
99.857
100.278
100.994
99.518
100.192
± 2.053
-100
2
103.448
100.595
103.961
102.478
105.667
105.401
103.170
102.871
103.755
103.612
103.496
± 1.437
3
100.649
101.095
101.367
99.272
103.217
100.450
102.280
100.669
100.758
103.392
101.315
± 1.291
4
100.372
100.930
100.443
99,674
100.135
99.803
100.000
100.151
100.120
100.000
100.163
± 0.355
5
115.101
110.532
118.344
109.390
103.239
121.038
113.190
105.533
105.945
116.580
111.889
± 5.944
·> The Evans Blue concentration was determined with the
polyethylene glycol method. V? calculated with Eq. 2 is
given as a percentage of VP calculated with Eq. 1 which
was used as a reference method (see text).
1. c0 = 1.015 - ^ i b
3. Cp obtained by linear extrapolation of the concentra-
tion vs time curve from 10-60 min
4. CQ obtained by semilogarithmic extrapolation of the
concentration vs time curve from 10-60 min
5. Co obtained by sem [logarithmic extrapolation of the
concentration vs time curve from 120-240 min.
tion in Eq. 2, c0 was calculated in five different ways and
the resulting V* expressed as a percentage of V* calcul-
ated with Eq. 1 in order to allow better mutual com-
parison.
Discussion
Since its introduction as an agent for fractionating pro-
teins (16), polyethylene glycol has also come into use
for the fractionation of serum proteins (17). Fractional
precipitation of proteins with polyethylene glycol in-
volves insolubilization of the components by super-
concentrating them in the inter-polyethylene glycol
spaces by volume exclusion, and does not involve any
chemical reaction by direct linkage or dehydration of the
proteins. It does not detach Evans Blue from albumin
which is shown by the fact that addition of one part
polyethylene glycol 240 g · Ã1 to one part plasma does
not lower the wavelength of maximum absorbance
(the wavelength of maximum absorbance of Evans Blue
in water and in polyethylene glycol 120 g · Ã1 is 610
nm). Although most experimental work on polyethylene
glycol fractionation was done with polyethylene glycol
6000, we preferred to use polyethylene glycol 4000 as
it is less viscous in solutions of the same concentration
(w/v). This is justified by the results shown in figure 1;
one to one addition of 240 g · Ã* polyethylene glycol
4000 to human and dog plasma precipitates more than
90% of the non-albumin fraction of the proteins, leaving
the albumin fraction in solution.
As the opacity of the plasma is predominantly linked to
the non-albumin fraction of the plasma proteins, precipi-
tation of the latter was expected to be effective in eli-
minating the absorbance of plasma at the wavelength
of maximum absorbance of Evans Blue. Our results
show that in human and dog plasma A
 62o and^4627
are indeed greatly reduced and their variability virtually
eliminated after treatment with polyethylene glycol.
Moreover, they show that the polyethylene glycol method
is not hampered by slight haemolysis of the plasmas
(tab. 1).
The data in table 2 show that the polyethylene glycol
method is very accurate and precise; its C,V. is better
than that of the radio-iodinated serum albumin deter-
mination (13). Data on the accuracy and precision of
the polyethylene glycol method in comparison with
other methods for the determination of Evans Blue
(tab. 3) show that the single-wavelength method does
not come up to the requirements of accuracy and pre-
cision, while both the two-wavelength method and the
acetone extraction method, though sufficiently accur-
ate, do lack in precision. The polyethylene glycol method
outranks the other methods in accuracy and precision,
and yet competes in easiness with the single-wavelength
method. The shortcomings of the single-wavelength
method, and to a lesser extent of the two-wavelength
J. Clin. Chem. Clin. Biochem. / Vol. 19,1981 / No. 9
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method, must be ascribed to the variation in plasma
background between different plasma samples even
within one and the same specimen over a short period
of time. In blood samples from three different dogs
taken every 10 min for 2 h, A
 627 of the plasmas was
found to vary at random between 0.044—0.169,
0.068-0.257 and 0.039-0.214, respectively. As for
the acetone extraction method, Tornberg (6) reported
a recovery of Evans Blue of 5.10 ± 0.05 mg · Ã1 at the
level of 5 mg · Ã1, but in our experience as in that of
others (1) the C.V. of this method is well over 2%. Yet,
the acetone extraction method remains the method of
choice where strongly haemolytic plasmas are con-
cerned. The scatter of the concentrations around the
disappearance curves (fig. 2) and the 95% confidence
interval of the values for V? (tab. 4) show that the
four different methods yield an estimate of V? in
accordance with their accuracy and precision. The poly-
ethylene glycol method yields an estimate 3 to 4 times
better than the acetone extraction method and the
two-wavelength method, which in turn yield a much
better estimate than the single-wavelength method.
To our knowledge Eq. 1 has not been used before for
calculating the plasma volume. In the initial period after
the injection of Evans Blue (0—60 min) the re-entry of
Evans Blue labelled albumin is negligible and the Evans
Blue disappearance curve is determined by mixing with
the plasma and by the transcapillary escape rate. When
mixing is complete (after about 10 min), Evans Blue
disappears from the plasma in a first-order fashion and
the concentration vs time curve is mono-exponential,
provided that no changes in the transcapillary escape of
albumin occur. Eq. 1 takes into account the whole
disappearance curve and, unlike the extrapolation pro-
cedures used to obtain cp for Eq. 2, does not neglect
the transcapillary loss in excess of the first-order elimi-
nation during the mixing time. Therefore, Eq. 1 was
chosen as a reference for the calculation of Vp from
Eq.2.
From table 5 it is obvious that the error resulting from
semilogarithmic extrapolation of the early disappearance
curve (procedure D) is negligible when the boundary con-
ditions for the use of Eq. 2 (high distribution velocity of
the indicator in comparison with its clearance and clear-
ance small in comparison with its distribution volume)
are fulfilled. When they are not met, the use of Eq. 1 is
preferable (18). The error resulting from linear extra-
polation of the early disappearance curve (procedure C)
is not negligible but still small, because over a short period
of time the disappearance curve can reasonably be approx-
imated by a linear function. The error resulting from
semilogarithmic extrapolation of the late disappearance
curve (procedure E) is considerable. The early disappear-
ance curve is virtually uninfluenced by re-entry of Evans
Blue into the vascular compartment, but re-entry becomes
gradually more prominent. The slope of the disappearance
curve flattens and c0 obtained by extrapolation strongly
underestimates its true value.
The error in the single-sample or two-sample procedures
can be significant when the transcapillary loss is faster
than average or when the mixing time is prolonged. Both
conditions, that are shown by the early disappearance
curve, are not recognized when a single- or two-sample
procedure is used. Moreover, the two-sample procedure
systematically overestimates Vp as the loss of indicator
is not corrected for.
The present investigation has shown that the Evans Blue
concentration in plasma can reliably be determined by
the polyethylene glycol method. This makes it possible
to determine F*7 with an indicator which upon injection
into the bloodstream binds exclusively to the patient's
own albumin and eliminates the necessity of using radio-
isotope-labelled foreign albumin which is generally less
accurately determined, is more expensive and has to be
obtained from hepatitis B antigen negative donors. With
a view to accuracy and precision, preference should be
given to the multiple sampling technique and the calcu-
lation of c0 using Eq. 1, or using Eq. 2. with c0 obtained
by semilogarithmic extrapolation to zero time of the
early disappearance curve, which usually can be reliably
carried out with 4 samples taken between 20 and 50 min
after injection. When the multiple sampling technique
is not feasible the single- or two-sample technique with
appropriate correction for the loss of indicator offers a
reasonable alternative, provided that transcapillary
escape rate and mixing time are not grossly abnormal.
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